We are pleased to announce that recruitment into the 3TR-ABC study will soon commence!
The first site to start is Bispebjerg Hospital in Copenhagen, Denmark, where all approvals from the authorities now are in place. From November 2021, all patients commencing on a biologic at Bispebjerg Hospital will be offered to participate in 3TR-ABC – thereby enabling us to learn more about severe asthma, and how we may improve existing treatments even more.
We look forward to keeping you updated on the progress of 3TR-ABC!